E-LIB Suche - Ergebnisse für: Dalens, Lorraine - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

A phase I study of the combination of atezolizumab, tiragol..:

Roussot, Nicolas ; Fumet, Jean-David ; Limagne, Emeric...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

2

FGF/FGFR genomic amplification as a predictive biomarker fo..:

Roussot, Nicolas ; Lecuelle, Julie ; Dalens, Lorraine..
Journal for ImmunoTherapy of Cancer. 11 (2023) 10 - p. e007763 , 2023

Link: https://doi.org/10.1136/..

3

Exome-Based Genomic Markers Could Improve Prediction of Che..:

Dalens, Lorraine ; Lecuelle, Julie ; Favier, Laure...
International Journal of Molecular Sciences. 24 (2023) 8 - p. 7592 , 2023

Link: https://doi.org/10.3390/..

4

Durable response of lung carcinoma patients to EGFR tyrosin..:

Dalens, Lorraine ; Niogret, Julie ; Richard, Corentin...
Molecular Cancer. 22 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

5

Is There a Role for Large Exome Sequencing in the Managemen..:

Dalens, Lorraine ; Niogret, Julie ; Kaderbhai, Courèche Guillaume.
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

6

Does large NGS panel analysed using exome tumour sequencing..:

Niogret, Julie ; Dalens, Lorraine ; Truntzer, Caroline...
Lung Cancer. 161 (2021) - p. 98-107 , 2021

Link: https://doi.org/10.1016/..

7

Durable response of lung carcinoma patients to EGFR tyrosin..:

Dalens, Lorraine ; Niogret, Julie ; Richard, Corentin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385908/. , 2023

Link: http://www.ncbi.nlm.nih...

8

FGF/FGFR genomic amplification as a predictive biomarker fo..:

Roussot, Nicolas ; Lecuelle, Julie ; Dalens, Lorraine..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618988/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Is There a Role for Large Exome Sequencing in the Managemen..:

Dalens, Lorraine ; Niogret, Julie ; Kaderbhai, Courèche Guillaume.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940536/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Additional file 1 of A phase I study of the combination of ..:

Nicolas Roussot ; Jean-David Fumet ; Emeric Limagne...
doi:10.6084/m9.figshare.24540556.v1. , 2023

Link: https://doi.org/10.6084/..

11

Durable response of lung carcinoma patients to EGFR tyrosin..:

Lorraine Dalens ; Julie Niogret ; Corentin Richard...
https://doi.org/10.1186/s12943-023-01829-4. , 2023

Link: https://doi.org/10.1186/..

12

A phase I study of the combination of atezolizumab, tiragol..:

Nicolas Roussot ; Jean-David Fumet ; Emeric Limagne...
https://doi.org/10.1186/s12885-023-11534-6. , 2023

Link: https://doi.org/10.1186/..

13

Exome-Based Genomic Markers Could Improve Prediction of Che..:

Lorraine Dalens ; Julie Lecuelle ; Laure Favier...
Molecular Oncology. , 2023

Link: https://doi.org/10.3390/..

14

Exome-Based Genomic Markers Could Improve Prediction of Che..:

Lorraine Dalens ; Julie Lecuelle ; Laure Favier...
https://www.mdpi.com/1422-0067/24/8/7592. , 2023

Link: https://doi.org/10.3390/..

15

FGF/FGFR genomic amplification as a predictive biomarker fo..:

Francois Ghiringhelli ; Caroline Truntzer ; Julie Lecuelle..
https://jitc.bmj.com/content/11/10/e007763.full. , 2023

Link: https://doi.org/10.1136/..

1-15